Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
How It Works

How It Works

Full MagLev™ Flow Technology: Easy on the blood

Designed for optimal hemocompatibility,1,2 Full MagLev Flow Technology can result in low hemolysis1 and low device-related thrombosis (2.5%).1,2

Watch this video to see how Full MagLev Flow Technology works.

Reduced blood trauma,3 minimized turbulence, maintained stability

Full MagLev Flow Technology provides a contact-free environment that features:

  • A free-floating magnetically levitated rotor to prevent surface-to-surface contact that could cause blood trauma
  • Wide blood-flow pathways and absence of seals, bearings and valves to minimize blood turbulence and stasis
  • Automatic rotor positioning that adjusts 50,000 times per second to maintain stable and consistent blood flow

 

Illustration demonstrating free-floating magnetically levitated rotor and blood pathways details.

This device is commercially available for use in select international markets.

References

  1. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag™ ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046
  2. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085
  3. Zhang, J., Gellman, B., Koert, A., Dasse, K. A., Gilbert, R. J., Griffith, B. P., & Wu, Z. J. (2006). Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artificial Organs, 30(3), 168-177. http://dx.doi.org/10.1111/j.1525-1594.2006.00203.x
INDICATIONS, SAFETY & WARNINGS

MAT-2012991 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO